Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 0: clinchem.2006.068593v1, 2006; 10.1373/clinchem.2006.068593
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
clinchem.2006.068593v1
52/8/1492    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhou, Y.
Right arrow Articles by Chong, S. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhou, Y.
Right arrow Articles by Chong, S. S.

Received on February 9, 2006
Accepted on May 31, 2006

Molecular Diagnostics and Genetics

Simplified Molecular Diagnosis of Fragile X Syndrome by Fluorescent Methylation-Specific PCR and GeneScan Analysis

Youyou Zhou 1*, Josephine M.S. Lum 1, Gare-Hoon Yeo 1, Jennifer Kiing 2, Stacey K.H. Tay 3, Samuel S. Chong 4*

1 Department of Pediatrics, Yong Loo Lin School of Medicine, National University of Singapore
2 Children's Medical Institute, National University Hospital, Singapore
3 Department of Pediatrics, Yong Loo Lin School of Medicine, National University of Singapore, and Children's Medical Institute, National University Hospital, Singapore
4 Department of Pediatrics, Yong Loo Lin School of Medicine, National University of Singapore, Children's Medical Institute and Department of Laboratory Medicine, National University Hospital, Singapore

* To whom correspondence should be addressed. E-mail: zhouyouyou{at}fudan.edu.cn.

Background: Fragile X syndrome (FXS), the most common cause of inherited mental impairment, is most commonly related to hyperexpansion and hypermethylation of a polymorphic CGG trinucleotide repeat in the 5' untranslated region of the FMR1 gene. Southern blot analysis is the most commonly used method for molecular diagnosis of FXS. We describe a simplified strategy based on fluorescent methylation-specific PCR (ms-PCR) and GeneScanTM analysis for molecular diagnosis of fragile X syndrome.

Methods: We used sodium bisulfite treatment to selectively modify genomic DNA from fragile X and NL lymphoblastoid cell lines and from patients. We then performed ms-PCR amplification using fluorescently-labeled primers complementary to modified methylated or unmethylated DNA. Amplification products were resolved by capillary electrophoresis. FMR1 variational status was determined by a combination of fluorescent peak sizes and patterns on the GeneScan electropherogram.

Results: DNA samples from male and female persons with known NL, prevariation, and full-variation FMR1 CGG repeats were analyzed. Each FMR1 genotype produced a unique GeneScan electropherogram pattern, thus providing a way to identify the various genotypes. The number of CGG repeats in all NL and prevariation alleles were determined accurately. Analysis by both the new assay and Southern blot of a family segregating with FXS showed complete concordance between both methods.

Conclusions: This simplified molecular diagnostic test, based on fluorescent methylation-specific PCR, may be a suitable alternative or complement to Southern blot analysis for the diagnosis of FXS.




The following articles in journals at HighWire Press have cited this article:


Home page
Clin. Chem.Home page
C. Dahl, K. Gronskov, L. A. Larsen, P. Guldberg, and K. Brondum-Nielsen
A Homogeneous Assay for Analysis of FMR1 Promoter Methylation in Patients with Fragile X Syndrome
Clin. Chem., April 1, 2007; 53(4): 790 - 793.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2006 by the American Association for Clinical Chemistry.